Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

G. J. van Baaren, M. M.C. Bruijn, Ben Mol

Research output: Contribution to journalLetter

LanguageEnglish
Pages142-143
Number of pages2
JournalAmerican Journal of Obstetrics and Gynecology
Volume218
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

@article{0eaac484d9f546cfbd5d03abbfc3b97f,
title = "Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing",
author = "{van Baaren}, {G. J.} and Bruijn, {M. M.C.} and Ben Mol",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ajog.2017.10.037",
language = "English",
volume = "218",
pages = "142--143",
journal = "American journal of obstetrics and gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

Randomized clinical trials are not always the best way to assess diagnostic tests : the case of fetal fibronectin testing. / van Baaren, G. J.; Bruijn, M. M.C.; Mol, Ben.

In: American Journal of Obstetrics and Gynecology, Vol. 218, No. 1, 01.01.2018, p. 142-143.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Randomized clinical trials are not always the best way to assess diagnostic tests

T2 - American journal of obstetrics and gynecology

AU - van Baaren, G. J.

AU - Bruijn, M. M.C.

AU - Mol, Ben

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85039436655&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2017.10.037

DO - 10.1016/j.ajog.2017.10.037

M3 - Letter

VL - 218

SP - 142

EP - 143

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

SN - 0002-9378

IS - 1

ER -